J Korean Med Assoc.  2018 Aug;61(8):509-521. 10.5124/jkma.2018.61.8.509.

Consensus guidelines for the definition of the end stage of disease and last days of life and criteria for medical judgment

Affiliations
  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Internal Medicine, Seoul Red Cross Hospital, Seoul, Korea.
  • 3Public Health Medical Service, Seoul National University Hospital, Seoul, Korea.
  • 4Department of Family Medicine, Korea University Guro Hospital, Seoul, Korea.
  • 5Korea National Institute for Bioethics Policy, Seoul, Korea.
  • 6Education Center for Public Health & Medicine, National Medical Center of Korea, Seoul, Korea.
  • 7Department of Family Medicine, Incheon St. Mary's Hospital, Incheon, Korea.
  • 8Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.
  • 9Hospice and Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
  • 10Department of Family Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • 11Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
  • 12Department of Family Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.
  • 13Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • 14Bobath Memorial Hospital, Seongnam, Korea.
  • 15Division of Oncology, Department of Internal Medicine, Catholic University St. Vincent's Hospital, Seoul, Korea.
  • 16Department of Hematology-Oncology, Ajou University Hospital, Suwon, Korea.
  • 17Department of Medical Education, Ewha Womans University College of Medicine, Seoul, Korea.
  • 18Department of Medical Humanities, Dong-A University College of Medicine, Busan, Korea.
  • 19Department of the History of Medicine and Medical Humanities, Seoul National University College of Medicine, Seoul, Korea.
  • 20Department of Medical Humanities and Ethics, Hanyang University College of Medicine, Seoul, Korea.
  • 21Department of Family Medicine, Dankook University College of Medicine, Cheonan, Korea.
  • 22Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. yskoh@amc.seoul.kr

Abstract

In Korea, the Hospice, Palliative Care, and Life-sustaining Treatment Decision-making Act was enacted in February 2016 in order to ensure that the patient's self-determination in end-of-life care processes is respected. To enhance physicians' understanding of this act and to provide proper criteria for medical judgment in variety of clinical settings, consensus guidelines were published in November 2016. In this article, the characteristics of these guidelines and related issues regarding the definitions of "˜the end stage of disease' and "˜last days of life' and the criteria for medical judgment are presented and summarized. According to the guidelines, the term "˜end stage of disease' refers to a state in which there is no possibility of a fundamental recovery and the symptoms are expected to worsen within months. The terms "˜the last days of life' and "˜the final days of life' refer to a state in which, despite treatment, the patient's condition is worsening and death is impending, with no possibility of recovery. The attending physician and another relevant specialist should both judge a patient's medical condition as either "˜end stage of disease' for hospice/palliative care or "˜the last days of life' for dying patient care according to the law. Caregivers should provide appropriate medical information to eligible patients for palliative or "˜end stage of disease' care through advance care planning. Therefore, it is critically necessary that caregivers understand the legitimate process of hospice/palliative and dying patient care based on the patient's wishes and best interests. Physicians should apply these consensus guidelines to eligible patients considering their clinical course and the patients' wishes.

Keyword

Consensus guideline; Palliative care; Hospice; End-of-life care; Advance care planning

MeSH Terms

Advance Care Planning
Caregivers
Consensus*
Hospices
Humans
Judgment*
Jurisprudence
Korea
Palliative Care
Patient Care
Specialization

Figure

  • Figure 1 The relationships of advance care planning (ACP) to advance directives (AD) and physician orders for life-sustaining treatment (POLST).

  • Figure 2 An example for implementation of advance care planning. AD, advance directive; EOL, end-of-life; POLST, physician orders for life-sustaining therapy.


Cited by  3 articles

Implementation of Antimicrobial Stewardship Programs in End-of-Life Care
Ki Tae Kwon
Infect Chemother. 2019;51(2):89-97.    doi: 10.3947/ic.2019.51.2.89.

Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer
Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, Hyun Ae Jung, Hee Kyung Ahn, Kyung Hee Lee, Min-ho Kim, Ju Hee Kim, Jaekyung Cheon, JinShil Kim, Su-Jin Koh
Cancer Res Treat. 2019;51(4):1632-1638.    doi: 10.4143/crt.2019.009.

Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea
Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim
Cancer Res Treat. 2022;54(1):20-29.    doi: 10.4143/crt.2021.131.


Reference

1. Koh Y. The ethics guideline of KAMS in the withdrawal of life-sustaining management. Seoul: Korean Academy of Medical Sciences;2002.
2. Koh Y, Heo DS, Yun YH, Moon JL, Park HW, Choung JT, Jung HS, Byun BJ, Lee YS. Charactersitics and issues of guideline to withdrawal of a life-sustaining therapy. J Korean Med Assoc. 2011; 54:747–757.
Article
3. Act on Hospice-palliative Care and Life-sustaining Treatment Decision-making. No. 14013 (Feb 3, 2016).
4. CDC Healthy Aging Program. Advance care planning: ensuring your wishes are known and honored if you are unable to speak for yourself [Internet]. Atlanta: Center for Diseases Control and Prevention;2012. cited 2018 Aug 1. Available from: https://www.cdc.gov/aging/pdf/advanced-care-planning-critical-issue-brief.pdf.
5. National Medical Ethics Committee. Guide for healthcare professionals on the ethical handling of communication in advance are planning. Singapore: National Medical Ethics Committee;2010.
6. National Health Service. More care, less pathway: a review of the liverpool care pathway [Internet]. London: GOV.UK;2013. cited 2018 Aug 1. Available from: https://www.gov.uk/government/publications/review-of-liverpool-care-pathway-for-dying-patients.
7. Chewning B, Bylund CL, Shah B, Arora NK, Gueguen JA, Makoul G. Patient preferences for shared decisions: a systematic review. Patient Educ Couns. 2012; 86:9–18.
Article
8. Schenker Y, Meisel A. Informed consent in clinical care: practical considerations in the effort to achieve ethical goals. JAMA. 2011; 305:1130–1131.
9. Wolff T, Whitehouse W. The death of DN: personal resuscitation plans. BMJ. 2009; 338:b2018.
10. Nelson JE, Cox CE, Hope AA, Carson SS. Chronic critical illness. Am J Respir Crit Care Med. 2010; 182:446–454.
Article
11. Glare P. Predicting and communicating prognosis in palliative care. BMJ. 2011; 343:d5171.
Article
12. Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. BMJ. 2005; 330:1007–1011.
Article
13. Highet G, Crawford D, Murray SA, Boyd K. Development and evaluation of the Supportive and Palliative Care Indicators Tool (SPICT): a mixed-methods study. BMJ Support Palliat Care. 2014; 4:285–290.
Article
14. Royal College of General Practitioners. The GSF prognostic indicator guidance [Internet]. London: Gold Standards Framework;2011. cited 2016 Aug 22. Available from: http://www.goldstandardsframework.org.uk/cd-content/uploads/files/General%20Files/Prognostic%20Indicator%20Guidance%20October%202011.pdf.
15. Gomez-Batiste X, Martinez-Munoz M, Blay C, Amblas J, Vila L, Costa X, Villanueva A, Espaulella J, Espinosa J, Figuerola M, Constante C. Identifying patients with chronic conditions in need of palliative care in the general population: development of the NECPAL tool and preliminary prevalence rates in Catalonia. BMJ Support Palliat Care. 2013; 3:300–308.
Article
16. Stuart B. The NHO Medical Guidelines for non-cancer disease and local medical review policy: hospice access for patients with diseases other than cancer. Hosp J. 1999; 14:139154.
Article
17. Centers for Medicare & Medicaid Services. Local coverage determination (LCD): hospice determining terminal status (L34538) [Internet]. Baltimore: Centers for Medicare & Medicaid Services;2015. cited 2016 Aug 22. Available from: https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=34538&ContrId=236&ver=5&ContrVer=2&CntrctrSelected=236*2&Cntrctr=236&LCntrctr=All&DocType=Active&bc=AAgCAAQAAAAA&.
18. General Medical Council. Treatment and care towards the end of life: good practice in decision making [Internet]. London: General Medical Council;2010. cited 2018 Aug 1. Available from: https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/treatment-and-care-towards-the-end-of-life.
19. European Association for Palliative Care. White paper on standards and norms for hospice and palliative care in Europe: part 1. Eur J Palliat Care. 2009; 16:278–289.
20. European Association for Palliative Care. White paper on standards and norms for hospice and palliative care in Europe: part 2. Eur J Palliat Care. 2010; 17:22–33.
21. Lee JK, Yun YH, An AR, Heo DS, Park BW, Cho CH, Kim S, Lee DH, Lee SN, Lee ES, Kang JH, Kim SY, Lee JL, Lee CG, Lim YK, Kim S, Choi JS, Jeong HS, Chun M. The understanding of terminal cancer and its relationship with attitudes toward end-of-life care issues. Med Decis Making. 2014; 34:720–730.
Article
22. NCCN roundtable: palliative care: providing comfort from a patient and provider perspective. J Natl Compr Canc Netw. 2016; 14:5 Suppl. 634–636.
23. Higginson IJ, Finlay IG. Improving palliative care for cancer. Lancet Oncol. 2003; 4:73–74.
Article
24. Kelley AS, Morrison RS. Palliative care for the seriously Ill. N Engl J Med. 2015; 373:747–755.
Article
25. Parikh RB, Kirch RA, Smith TJ, Temel JS. Early specialty palliative care: translating data in oncology into practice. N Engl J Med. 2013; 369:2347–2351.
Article
26. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363:733–742.
Article
27. Calton BA, Alvarez-Perez A, Portman DG, Ramchandran KJ, Sugalski J, Rabow MW. The current state of palliative care for patients cared for at leading US cancer centers: the 2015 NCCN palliative care survey. J Natl Compr Canc Netw. 2016; 14:859–866.
Article
28. Albizu-Rivera A, Portman DG, Thirlwell S, Codada SN, Donovan KA. Implementation of NCCN Palliative Care Guidelines by member institutions. Support Care Cancer. 2016; 24:929–932.
Article
29. Kim SH, Shin DW, Kim SY, Yang HK, Nam E, Jho HJ, Ahn E, Cho BL, Park K, Park JH. Terminal versus advanced cancer: do the general population and health care professionals share a common language? Cancer Res Treat. 2016; 48:759–767.
Article
30. Tolle SW, Back AL, Meier DE. Clinical decisions: end-of-life advance directive. N Engl J Med. 2015; 372:667–670.
31. Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014; 383:1721–1730.
Article
32. Morrison RS, Meier DE. Clinical practice: palliative care. N Engl J Med. 2004; 350:2582–2590.
33. May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, Hay P, Johnson M, Palfreeman A, Gilson R, Chadwick D, Martin F, Hill T, Walsh J, Post F, Fisher M, Ainsworth J, Jose S, Leen C, Nelson M, Anderson J, Sabin C. UK Collaborative HIV Cohort (UK CHIC) Study. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014; 28:1193–1202.
Article
34. Fausto JA Jr, Selwyn PA. Palliative care in the management of advanced HIV/AIDS. Prim Care. 2011; 38:311–326.
35. Rhodes RL, Nazir F, Lopez S, Xuan L, Nijhawan AE, Alexander-Scott NE, Halm EA. Use and predictors of end-of-life care among HIV patients in a safety net health system. J Pain Symptom Manage. 2016; 51:120–125.
Article
36. Selwyn PA. Palliative care for patient with human immunodeficiency virus/acquired immune deficiency syndrome. J Palliat Med. 2005; 8:1248–1268.
Article
37. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. [place unknown]: Global Initiative for Chronic Obstructive Lung Disease;2016.
38. Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med. 2006; 166:326–331.
Article
39. Seamark DA, Seamark CJ, Halpin DM. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J R Soc Med. 2007; 100:225–233.
Article
40. Korean Association for the Study of the Liver-Clinical Research Center for the Liver Cirrhosis. Management guideline for liver cirrhosis. . Seoul: Korean Association for the Study of the Liver-Clinical Research Center for the Liver Cirrhosis;2011.
41. Ministry of Health and Welfare. Criteria of disability grades. Sejong: Ministry of Health and Welfare;2015.
42. Ranyon BA. Management of adult patients with ascites due to cirrhosis: update 2012 [Internet]. Alexandria: American Association for the Study of Liver Diseases;2012. cited 2018 Aug 1. Available from: https://www.aasld.org/sites/default/files/guideline_documents/141020_Guideline_Ascites_4UFb_2015.pdf.
43. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice Guidelines Committee of the American Association for the Study of Liver Diseases. Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007; 46:922–938.
Article
44. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the study of liver diseases and the European Association for the study of the liver. Hepatology. 2014; 60:715–735.
Article
45. Ministry of Health and Welfare. National Pension Service. Guideline of disability grade in national pension. Sejong: Ministry of Health and Welfare;2016.
46. Statistics Korea. Statistical database: deaths and death rates by cause (103 item)/by sex/by age (five-year age) [Internet]. Deajeon: Statistics Korea;2016. cited 2018 Aug 1. Available from: http://www.kostat.go.kr/portal/korea/kor_nw/2/1/index.board?bmode=read&aSeq=356345.
47. McDaid P. A quick guide to identifying patients for supportive and palliative care. London: National Health System;2011.
48. Huynh BC, Rovner A, Rich MW. Identification of older patients with heart failure who may be candidates for hospice care: development of a simple four-item risk score. J Am Geriatr Soc. 2008; 56:1111–1115.
Article
49. Holloway RG, Arnold RM, Creutzfeldt CJ, Lewis EF, Lutz BJ, McCann RM, Rabinstein AA, Saposnik G, Sheth KN, Zahuranec DB, Zipfel GJ, Zorowitz RD. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology. Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45:1887–1916.
50. Murray AM, Arko C, Chen SC, Gilbertson DT, Moss AH. Use of hospice in the United States dialysis population. Clin J Am Soc Nephrol. 2006; 1:1248–1255.
Article
51. Cohen LM, Germain M, Poppel DM, Woods A, Kjellstrand CM. Dialysis discontinuation and palliative care. . Am J Kidney Dis. 2000; 36:140–144.
Article
52. Germain MJ, Cohen LM, Moss AH. Strategies for timely and effective hospice discussions: end-stage renal disease. Ann Intern Med. 2007; 147:816.
Article
53. Holley JL. Palliative care in end-stage renal disease: illness trajectories, communication, and hospice use. Adv Chronic Kidney Dis. 2007; 14:402–408.
Article
54. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med. 2007; 146:177–183.
Article
55. Germain MJ, Cohen LM. Maintaining quality of life at the end of life in the end-stage renal disease population. Adv Chronic Kidney Dis. 2008; 15:133–139.
Article
56. Choi YS, Kim HS. Hospice medical guideline, non-cancer diseases. Korean J Hosp Palliat Care. 2010; 13:69–75.
Article
57. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc. 2000; 48:938–942.
Article
58. Richfield EW, Jones EJ, Alty JE. Palliative care for Parkinson's disease: a summary of the evidence and future directions. Palliat Med. 2013; 27:805–810.
Article
59. Boersma I, Miyasaki J, Kutner J, Kluger B. Palliative care and neurology: time for a paradigm shift. Neurology. 2014; 83:561–567.
Article
60. Boersma I, Jones J, Carter J, Bekelman D, Miyasaki J, Kutner J, Kluger B. Parkinson disease patients' perspectives on palliative care needs: What are they telling us? Neurol Clin Pract. 2016; 6:209–219.
Article
61. Bede P, Oliver D, Stodart J, van den Berg L, Simmons Z, O Brannagain D, Borasio GD, Hardiman O. Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. J Neurol Neurosurg Psychiatry. 2011; 82:413–418.
Article
62. EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2012; 19:360–375.
63. Luchins DJ, Hanrahan P, Murphy K. Criteria for enrolling dementia patients in hospice. J Am Geriatr Soc. 1997; 45:1054–1059.
Article
64. Mitchell SL, Teno JM, Kiely DK, Shaffer ML, Jones RN, Prigerson HG, Volicer L, Givens JL, Hamel MB. The clinical course of advanced dementia. N Engl J Med. 2009; 361:1529–1538.
Article
65. Mitchell SL, Miller SC, Teno JM, Davis RB, Shaffer ML. The advanced dementia prognostic tool: a risk score to estimate survival in nursing home residents with advanced dementia. J Pain Symptom Manage. 2010; 40:639–651.
Article
66. Mitchell SL, Miller SC, Teno JM, Kiely DK, Davis RB, Shaffer ML. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA. 2010; 304:1929–1935.
Article
67. Carson SS, Bach PB, Brzozowski L, Leff A. Outcomes after long-term acute care. An analysis of 133 mechanically ventilated patients. Am J Respir Crit Care Med. 1999; 159:1568–1573.
Article
68. Primary Palliative Care Research Group. Supportive and pal-liative care indicators tool (SPICT). Edinburgh: University of Edinburgh;2016.
69. National Clinical Guideline Centre. Care of dying adults in the last days of life. London: National Institute for Health and Care Excellence;2015.
70. Annich GM. ECMO: extracorporeal cardiopulmonary sup-port in critical care. 4th ed. Michigan: Extracorporeal Life Support Organization;2012.
71. PREMERA. Extracorporeal membrane oxygenation for adult conditions [Internet]. [place unknown]: PREMERA;2018. cited 2018 Aug 1. Available from: https://www.premera.com/medicalpolicies/8.01.60.pdf.
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr